Delivery Order SPE2DB22D3004-SPE2DB24FPX06
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EMERPHED 50 MG/10 ML SYRINGE 10ML. The award has a potential value of $1,968.18 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania. This order is placed under an...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of EMERPHED 25 MG/5 ML SYRINGE 5ML pharmaceutical products. The $2,612.11 contract has a completion date of February 7, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp, a for-profit company, serves as the prime contractor and is not utilizing any set-aside designations. This...
- This delivery order award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp for the supply of 4,565,295 units of the pharmaceutical product EMERPHED 50 MG/10 ML SYRINGE 10ML. The $1,640.15 firm-fixed price contract has a period of performance through July 31, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medical commodities to federal agencies under various Indefinite Delivery Contracts, including a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product, with a completion date of March 21, 2024 and a ceiling value of $2,501.34. Amerisourcebergen Drug Corp has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of EMERPHED 50 MG/10 ML SYRINGE 10ML, a pharmaceutical product. The firm fixed-price delivery order, valued at $1,640.15, has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to supply a wide range of medical commodities,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,112.76, is for the delivery of EMERPHED 50 MG/10 ML VIAL 10ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 20, 2025. The contract was awarded on March 19, 2025 and does not have a set-aside designation,...
- This is a federal contract award valued at $2,952.27 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide 4564287327 - EMERPHED 50 MG/10 ML SYRINGE 10ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an Ultimate Completion Date of April 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies...
- The Defense Logistics Agency awarded a $2,168.54 delivery order to AmerisourceBergen Drug Corp for EMERPHED 25 MG/5 ML syringes (5 ML) on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML, a critical medical product. It is a firm-fixed price contract with a ceiling value of $1,324.12 and a period of performance through October 8, 2024. The contract does not have a set-aside designation. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for EMERPHED 50 mg/10 mL vials with a ceiling value of $1,390.95 and a firm fixed price structure. This non-set-aside competitive award is classified as a delivery order, with ultimate completion scheduled for August 11, 2025. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the pharmaceutical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPX06Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract (SPE2DB22D3004|SPE2DB24FPX06) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EMERPHED 50 MG/10 ML SYRINGE 10ML pharmaceutical products. The $1,312.12 delivery order has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.
Generated 7/5/24, 9:31 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 4/5/24 |